Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001829126-25-001314
Filing Date
2025-02-28
Accepted
2025-02-28 11:31:09
Documents
1
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 ownership.html 3  
1 FORM 3 ownership.xml 3 2158
  Complete submission text file 0001829126-25-001314.txt   3742
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LOT 3313 TAMAN SINARAN JALAN ISMAIL PET RA TANAH MERAH, KELANTAN N8 17500
Business Address
Kiu Cu Seng (Reporting) CIK: 0001891617 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 25685132